P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA

Bibliographic Details
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000547978.61156.2d
_version_ 1797285871679963136
collection DOAJ
first_indexed 2024-03-07T18:09:40Z
format Article
id doaj.art-72cd639e7dc24d7db52fffab1decba56
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:09:40Z
publishDate 2018-10-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-72cd639e7dc24d7db52fffab1decba562024-03-02T07:47:34ZengWileyHemaSphere2572-92412018-10-0125310.1097/01.HS9.0000547978.61156.2d201810003-00135P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMAhttp://journals.lww.com/10.1097/01.HS9.0000547978.61156.2d
spellingShingle P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
HemaSphere
title P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
title_full P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
title_fullStr P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
title_full_unstemmed P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
title_short P135 (0160) BRENTUXIMAB-VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
title_sort p135 0160 brentuximab vedotin bendamustine a highly effective salvage treatment un refractory relapsed patients with hodgkin lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000547978.61156.2d